A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial
Publication
, Journal Article
Newby, LK
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
July 1, 2000
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
July 1, 2000
Volume
36
Issue
1
Start / End Page
319 / 320
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Newby, L. K. (2000). A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 36(1), 319–320.
Newby, L. K. “A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 36, no. 1 (July 1, 2000): 319–20.
Newby LK. A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2000 Jul 1;36(1):319–20.
Newby, L. K. “A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 36, no. 1, ELSEVIER SCIENCE INC, July 2000, pp. 319–20.
Newby LK. A randomized comparison of sibrafiban, an oral glycoprotein (GP) IIb/IIIa receptor antagonist, with and without aspirin versus aspirin after acute coronary syndromes (ACS): Results of the second symphony trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2000 Jul 1;36(1):319–320.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
July 1, 2000
Volume
36
Issue
1
Start / End Page
319 / 320
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology